VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTGN VistaGen Therapeutics, Inc.

盘前交易 07-23 05:25:03 EDT

3.92

+0.26

+7.10%

最高3.96	最低3.62	成交量4.91万
今开3.62	昨收3.66	日振幅9.29%
总市值1.06亿	流通市值6,078万	总股本2,705万
成交额18.62万	换手率0.32%	流通股本1,550万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics, Inc.","latestPrice":3.92,"timestamp":1721678400000,"preClose":3.66,"halted":0,"volume":49138,"delay":0,"floatShares":15504664,"shares":27050585,"eps":-1.52,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.26,"latestTime":"07-23 05:25:03 EDT","open":3.62,"high":3.96,"low":3.62,"amount":186190.441923,"amplitude":0.092896,"askPrice":4.28,"askSize":100,"bidPrice":3.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.52,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721741400000},"adr":0,"listingDate":1462939200000,"adjPreClose":3.92,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.81,"preClose":3.92,"latestTime":"19:55 EDT","volume":963,"amount":3671.07,"timestamp":1721692523610},"volumeRatio":0.5517379216801181,"impliedVol":0.9164,"impliedVolPercentile":0.3546},"requestUrl":"/m/hq/s/VTGN","defaultTab":"news","newsList":[{"id":"2453712721","title":"Vistagen Therapeutics, Inc.盘中异动 股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453712721","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453712721?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:33","pubTimestamp":1721676783,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时33分，Vistagen Therapeutics, Inc.股票出现异动，股价大幅上涨5.74%。截至发稿，该股报3.87美元/股，成交量3.2305万股，换手率0.12%，振幅6.83%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.93%、117.41%、86.85%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.，振幅分别为53.55%、44.07%、37.06%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723033303aefacee9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723033303aefacee9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VTGN","LENZ"],"gpt_icon":0},{"id":"2450809072","title":"Vistagen Therapeutics, Inc.盘中异动 下午盘大幅拉升5.16%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450809072","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450809072?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:30","pubTimestamp":1720553401,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时30分，Vistagen Therapeutics, Inc.股票出现波动，股价快速拉升5.16%。截至发稿，该股报3.57美元/股，成交量7.1675万股，换手率0.27%，振幅3.54%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、180 Life Sciences Corp.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为13243.62%、3230.25%、368.30%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为468.99%、196.29%、134.00%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710033002aef8c223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710033002aef8c223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTGN","LENZ","BK4139"],"gpt_icon":0},{"id":"2442328785","title":"Vistagen Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2442328785","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442328785?lang=zh_cn&edition=full","pubTime":"2024-06-12 06:08","pubTimestamp":1718143705,"startTime":"0","endTime":"0","summary":"   * Vistagen Therapeutics Inc   报告，截至3月底的季度调整后每股亏损25美分，高于去年同期的每股收益1.75美元。四位分析师对该季度的平均预期是每股亏损 36 美分。华尔街预期为每股-46美分至-27美分。* Vistagen Therapeutics Inc 公布的本季度每股收益为亏损 25 美分。* 该公司当季亏损 952 万美元。* Vistagen Therapeutics Inc 的股价本季度下跌了 30.3%，今年迄今为止下跌了 28.4%。华尔街对 Vistagen Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN","LENZ"],"gpt_icon":0},{"id":"2411319263","title":"Vistagen Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2411319263","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411319263?lang=zh_cn&edition=full","pubTime":"2024-02-14 07:32","pubTimestamp":1707867161,"startTime":"0","endTime":"0","summary":"   * Vistagen Therapeutics Inc   报告，截至12月底的季度调整后每股亏损22美分，高于去年同期的每股收益1.50美元。四位分析师对该季度的平均预期是每股亏损 30 美分。华尔街预期为每股-39美分至-27美分。* 营收同比增长 128.6%，达到 41.14 万美元；分析师预期为 54.45 万美元。* Vistagen Therapeutics Inc 公布的本季度每股收益为亏损 22 美分。* 该公司当季亏损 635 万美元。* Vistagen Therapeutics Inc 的股价本季度上涨了 0.2%。华尔街对 Vistagen Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元。本摘要由 LSEG 2 月 13 日 11:32 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2410091606","title":"Vistagen Therapeutics Inc    预计每股亏损 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2410091606","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410091606?lang=zh_cn&edition=full","pubTime":"2024-02-10 06:48","pubTimestamp":1707518889,"startTime":"0","endTime":"0","summary":"   * Vistagen Therapeutics Inc    将于2月13日公布截至2023年12月31日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Vistagen Therapeutics Inc 的平均预期是每股亏损 30 美分。* 华尔街对 Vistagen Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 4.90 美元。2月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2408795293","title":"Vistagen Therapeutics Inc    预计每股亏损 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2408795293","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408795293?lang=zh_cn&edition=full","pubTime":"2024-02-03 05:13","pubTimestamp":1706908392,"startTime":"0","endTime":"0","summary":"   * Vistagen Therapeutics Inc    预计将于2月5日公布截至2023年12月31日的季度业绩(预计)，季度收入将有所增长。* LSEG 分析师对 Vistagen Therapeutics Inc 的平均预期是每股亏损 30 美分。* 华尔街对 Vistagen Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 4.80 美元。2月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vistagen.com","stockEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.1701},{"period":"3month","weight":-0.1884},{"period":"6month","weight":-0.1842},{"period":"1year","weight":1.1075},{"period":"ytd","weight":-0.2374}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vistagen Therapeutics, Inc.成立于1998年5月26日，是一家临床阶段的生物制药公司，致力于开发新一代治疗焦虑、抑郁和某些其他中枢神经系统(CNS)疾病的疗法，这些疾病目前的治疗方案不足，导致全球大型和不断增长的市场存在大量未满足的需求，产品线包括三种临床阶段的CNS候选产品，PH94B、PH10和AV-101，每种产品都具有不同的作用机制，迄今为止在所有临床研究中都具有卓越的安全性，并且在多种CNS适应症中具有治疗潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.1807},{"month":2,"riseRate":0.25,"avgChangeRate":-0.126424},{"month":3,"riseRate":0.25,"avgChangeRate":-0.122695},{"month":4,"riseRate":0.625,"avgChangeRate":0.021656},{"month":5,"riseRate":0.5,"avgChangeRate":-0.012139},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.071169},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062358},{"month":8,"riseRate":0.75,"avgChangeRate":0.313584},{"month":9,"riseRate":0.25,"avgChangeRate":0.050543},{"month":10,"riseRate":0.375,"avgChangeRate":-0.09375},{"month":11,"riseRate":0.375,"avgChangeRate":-0.095722},{"month":12,"riseRate":0.75,"avgChangeRate":0.308966}],"exchange":"NASDAQ","name":"VistaGen Therapeutics, Inc.","nameEN":"VistaGen Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VistaGen Therapeutics, Inc.(VTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VistaGen Therapeutics, Inc.,VTGN,VistaGen Therapeutics, Inc.股票,VistaGen Therapeutics, Inc.股票老虎,VistaGen Therapeutics, Inc.股票老虎国际,VistaGen Therapeutics, Inc.行情,VistaGen Therapeutics, Inc.股票行情,VistaGen Therapeutics, Inc.股价,VistaGen Therapeutics, Inc.股市,VistaGen Therapeutics, Inc.股票价格,VistaGen Therapeutics, Inc.股票交易,VistaGen Therapeutics, Inc.股票购买,VistaGen Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VistaGen Therapeutics, Inc.(VTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况